With the many cannabis products that exist, it was only a matter time until we heard about Cannabis Beer. Now Canada is bringing it to the people. An article in Forbes sites the following:
“Perhaps it will be called Cannabeer. Whatever it’s called, according to Lauren Eads, the Drinksbusiness.com, Canada’s Province Brands (PB) “filed the provisional patent for the ‘world’s first beers brewed from the cannabis plant.’”
Other companies have produced wine and beer laced with cannabis, but according to the Drinksbusiness article, PB is the first company with a global reach to produce beers brewed entirely from the cannabis plant. The company bills its products as “alcohol-free, yet highly intoxicating.” They claim the products are low in calories, low in sugar, and — very important in today’s consumer climate — gluten free. The patent filing is about six months old.
Believing that cannabis will be recreationally legal in every one of the 50 US states sometime in the near future, the giant Constellation Brands (CB) based in Fairport, New York wanted to be at the head of the class. In October, 2017 CB got into cannabis with a 10 percent stake (worth $197.5 million) in Canadian Canopy Growth Corporation, which bills itself as a “world leading diversified cannabis company.”
PB kicked off in 2016. Co-founder and CEO, Dooma Wendschuh told the Drinksbusiness that CB’s recent interest in cannabis has helped his company attract funding sources. Wendschuh made a point of mentioning the fact that it was not a tobacco company to jump into the cannabis market, as had been assumed would happen, but a drinks conglomerate. He believes CB’s interest validates his company’s direction.
Wendschuh also told the Drinksbusiness his company will produce great-tasting beers. More important, the company’s patent locks valuable intellectual property in its grip. He claims his developmental team has decades of combined experience in the beverage alcohol industry.
But if CB believes cannabis legalization is coming to the US, why invest in Canada?
Seventeen years ago Canada became the first country to legalize medical marijuana . Today, the Canadian federal government is on the verge of legalizing cannabis edibles and beverages — the government intimated that will probably happen by 2019. According to the Winebusiness report, CB appears to have initial plans “to make alcohol-free cannabis drinks like sodas, coffees and fruit-based drinks.”
There’s no guarantee that Canada’s legislature will give the green light in 2019, but there certainly is reason to have faith. Not so in the US.
Today, medicinal marijuana is legal in 21 US states, and it’s true that recreational marijuana is legal in eight. It’s also true that the US cannabis industry was worth almost $7 billion in 2016, and the industry expects its value to rise to $50 billion by 2026. But that is not the whole story.
The US federal government is at odds with the states on the cannabis issue. Federal government laws make it difficult for cannabis businesses to do simple necessary things like maintain a bank account or file federal taxes, and the US Attorney General (AG), Jeff Sessions has made threats to hold states and businesses accountable to federal statutes. Under the statutes, marijuana remains a Schedule I drug, which, according to federal law, means it is “a drug with no currently accepted medical use and a high potential for abuse.” That places cannabis in a class with heroin, lysergic acid diethylamide (LSD), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone (qualude).
Recently, while being interviewed about the latest U.S. Justice Department’s war on drugs, this time precipitated by national opiod abuse, AG Sessions said, “We think a lot of this is starting with marijuana and other drugs.”